Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Net Margin % : 13.79% (As of Dec. 2023)

Taiwan Advance Bio-Pharmaceutical Net Margin % Chart

Taiwan Advance Bio-Pharmaceutical Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Net Margin %		Get a 7-Day Free Trial					-84.87	-36.67	-48.70	1.00	-3.38

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial															-69.83	4.67	-3.11	-28.33	13.79

Competitive Comparison of Taiwan Advance Bio-Pharmaceutical's Net Margin %

For the Biotechnology subindustry, Taiwan Advance Bio-Pharmaceutical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taiwan Advance Bio-Pharmaceutical's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Advance Bio-Pharmaceutical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Taiwan Advance Bio-Pharmaceutical's Net Margin % falls into.

Taiwan Advance Bio-Pharmaceutical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Taiwan Advance Bio-Pharmaceutical's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Taiwan Advance Bio-Pharmaceutical's Net Margin for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Advance Bio-Pharmaceutical  (ROCO:4186) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Taiwan Advance Bio-Pharmaceutical Net Margin % Related Terms

Thank you for viewing the detailed overview of Taiwan Advance Bio-Pharmaceutical's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Business Description